日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Retraction Note: APEX1/miR-24 axis: a promising therapeutic target in endometriosis

撤稿声明:APEX1/miR-24轴:子宫内膜异位症的一个有前景的治疗靶点

Tan, Aili; Ruan, Peng; Sun, Pengxing

Targeting EphA2 suppresses the proliferation, migration and invasion of endometriosis via the AMPK signaling pathway.

靶向 EphA2 可通过 AMPK 信号通路抑制子宫内膜异位症的增殖、迁移和侵袭

Yang Chaoyi, Wang Shujun, Li Mengru, Pang Xiangli, Tan Aili

Machine-learning-derived prediction models of recurrence of ovarian endometriosis after laparoscopic surgery

基于机器学习的腹腔镜手术后卵巢子宫内膜异位症复发预测模型

Li, Mengru; Wang, Shujun; Tan, Aili; Yang, Chaoyi; Xie, Qingzhen

[Retracted] miR‑187 inhibits the growth of cervical cancer cells by targeting FGF9

[已撤稿] miR-187 通过靶向 FGF9 抑制宫颈癌细胞的生长

Liang, Hua; Luo, Ruoyu; Chen, Xiaoqi; Zhao, Yuzi; Tan, Aili

Prognostic Impact of Memory CD8(+) T Cells on Immunotherapy in Human Cancers: A Systematic Review and Meta-Analysis

记忆性CD8(+) T细胞对人类癌症免疫治疗预后的影响:系统评价和荟萃分析

Jin, Yao; Tan, Aili; Feng, Jia; Xu, Zexi; Wang, Peiwei; Ruan, Peng; Luo, Ruijun; Weng, Yiming; Peng, Min

Co-expression network analysis of the lncRNAs and mRNAs associated with cervical cancer progression

宫颈癌进展相关lncRNA和mRNA的共表达网络分析

Jiang, Li; Hong, Li; Yang, Wenwu; Zhao, Yuzi; Tan, Aili; Li, Yang

miR-187 inhibits the growth of cervical cancer cells by targeting FGF9

miR-187通过靶向FGF9抑制宫颈癌细胞的生长。

Liang, Hua; Luo, Ruoyu; Chen, Xiaoqi; Zhao, Yuzi; Tan, Aili